CHOP Hematologist Hails Approval of Two New Drugs To Manage Sickle Cell Disease (SCD)

Published on

CHOP in the Media

The US Food and Drug Administration has granted accelerated approval to two novel drugs to treat sickle cell disease. Kim Smith-Whitley, MD, Director of the Comprehensive Sickle Cell Center and the Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED), says these medications will augment the cutting-edge treatments CHOP offers to better manage this debilitating disease, as discussed in this Philadelphia Inquirer article.